0.6664
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTXR Giù?
Forum
Previsione
Frazionamento azionario
Citius Pharmaceuticals Inc Borsa (CTXR) Ultime notizie
Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization – Company AnnouncementFT.com - Financial Times
Citius Pharmaceuticals secures $5M through equity offering - MSN
Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering - Quantisnow
CTXR Stock Chart | CITIUS PHARMACEUTICALS INC (NASDAQ:CTXR) - ChartMill
Citius Oncology sees first international shipment of LYMPHIR to Europe - ROI-NJ
CTXR Price Today: Citius Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Citius Expands LYMPHIR Access with First European Shipment - TipRanks
Citius Oncology Begins First European Expansion of LYMPHIR - TipRanks
Citius Pharmaceuticals (Nasdaq: CTXR) unit sends first LYMPHIR shipment to Europe - Stock Titan
Citius Oncology Ships First International Order of LYMPHIR™ to E - GuruFocus
Citius Pharmaceuticals expands LYMPHIR global reach with initial European shipment - Traders Union
First LYMPHIR cancer-drug shipment reaches Europe via named-patient access - Stock Titan
Citius Oncology Ships First International Order of LYMPHIR™ to Europe - Sahm
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules - marketscreener.com
Citius Pharmaceuticals Raises $5 Million in Securities Offering - The Globe and Mail
Citius Pharmaceuticals Announces $5 Million Registered Direct Offering to Support LYMPHIR Launch and Product Development - Minichart
Citius Pharmaceuticals raises $5M in registered direct offering By Investing.com - Investing.com Australia
Citius Pharmaceuticals closes $5M stock offering By Investing.com - Investing.com Australia
Citius Pharmaceuticals (NASDAQ: CTXR) closes $5 million stock and warrant financing - Stock Titan
Citius Pharmaceuticals closes $5M stock offering - Investing.com
Citius Pharmaceuticals Secures $5M Through Equity Offering - Yahoo Finance
What's Behind The Drop In Citius Pharmaceuticals? - Benzinga
Citius Pharmaceuticals (NASDAQ: CTXR) offers 4.73M shares and warrants in $4.5M raise - Stock Titan
Citius Pharmaceuticals raises $5M in registered direct offering - Investing.com
Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules - 富途牛牛
Citius Pharmaceuticals to raise $5M in equity offering - MSN
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Citius Pharma Secures $5M to Fuel LYMPHIR Launch Amid Dilution Concerns - BriefGlance
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
Citius Oncology announces pricing of $9 million public offering - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
We Might See A Profit From Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Soon - Yahoo Finance
Citius Pharma (CTXR) Stock: Final Thoughts (Modest Uptick) 2026-04-20Community Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai
CTXR Stock Price, Quote & Chart | CITIUS PHARMACEUTICALS INC (NASDAQ:CTXR) - ChartMill
Can Citius Pharmaceuticals Inc lead its sector in growth2026 Weekly Recap & Technical Confirmation Trade Alerts - baoquankhu1.vn
Risk Report: What is Citius Pharmaceuticals Incs 5 year growth outlook2026 Technical Patterns & Weekly Breakout Stock Alerts - baoquankhu1.vn
Will Citius Pharma (CTXR) Stock Grow in 2026 | Price at $0.80, Down 1.24%Community Volume Signals - Xã Vĩnh Công
Retail Trends: Is Citius Pharmaceuticals Inc in a long term uptrend2026 Snapshot & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Citius Pharmaceuticals accelerates clinical momentum for LYMPHIR as oncology interest climbs - Traders Union
Is Citius Pharma (CTXR) Stock Overvalued Now | Price at $0.83, Up 5.07%Momentum Investing - UBND thành phố Hải Phòng
Support Test: What is Citius Pharmaceuticals Incs 5 year growth outlookWeekly Gains Report & Safe Capital Allocation Plans - baoquankhu1.vn
Citius Pharmaceuticals, Inc. Files Form 8-K Current Report with SEC on April 6, 2026 - Minichart
Trading Recap: Why is Cincinnati Financial Corporation stock going upBull Run & AI Forecasted Entry/Exit Points - baoquankhu1.vn
EPS Watch: What is Citius Pharmaceuticals Incs 5 year growth outlookTrade Analysis Report & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Citius Pharmaceuticals elects board members and ratifies auditor at annual meeting - Investing.com Australia
Citius Pharmaceuticals elects board members and ratifies auditor at annual meeting By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):